FDA NDC Directory · JSON-LD · Markdown

Norpace CR

NDC 0025-2732 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Generic namedisopyramide phosphate
Labeler / ManufacturerPfizer Laboratories Div Pfizer Inc
Marketing categoryNew Drug Application (innovator) · App NDA018655
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsDISOPYRAMIDE PHOSPHATE (100 mg/1)
Marketing started19820720
Package count1

External sources

Source: openFDA. Public-domain (CC0).